Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on December 11.Pick the ...

Merck MRK announced that the FDA has accepted the biologics license application (BLA) for its investigational prophylactic ...

Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

The FDA has started a review of MSD's respiratory syncytial virus (RSV) antibody clesrovimab, with a verdict due in the ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

Without careful dissection of the ways in which biases can be encoded into artificial intelligence (AI) health technologies, ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 38,541.57 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and Robert F. Kennedy Jr. as the possible HHS lead.

The meningococcal B vaccine Bexsero is funded for people aged 13-25 who are entering their first year of close-living ...